This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis
Scientific Reports Open Access 14 March 2024
-
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
Clinical Proteomics Open Access 08 November 2023
-
Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity
Breast Cancer Research Open Access 07 October 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Golub, T.R. et al. Science 286, 531–537 (1999).
Gentleman, R. Stat. Appl. Genet. Mol. Biol. [online] 4, 2 (2005) <http://www.bepress.com/sagmb/vol4/iss1/art2>.
Author information
Authors and Affiliations
Supplementary information
Supplementary Figure 1
GenePattern functional architecture. (PDF 553 kb)
Supplementary Figure 2
GenePattern software architecture. (PDF 633 kb)
Supplementary Table 1
Microarray analysis software comparison. (PDF 24 kb)
Supplementary Table 2
Contents of the GenePattern module repository. (PDF 12 kb)
Rights and permissions
About this article
Cite this article
Reich, M., Liefeld, T., Gould, J. et al. GenePattern 2.0. Nat Genet 38, 500–501 (2006). https://doi.org/10.1038/ng0506-500
Issue Date:
DOI: https://doi.org/10.1038/ng0506-500
This article is cited by
-
In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis
Oncogene (2024)
-
Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis
Scientific Reports (2024)
-
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma
Annals of Hematology (2024)
-
Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma
BMC Genomics (2023)
-
Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
BMC Bioinformatics (2023)